Characteristic | Intervention Group No. (%) | Control Group No. (%) | P Value |
---|---|---|---|
Total | 6,177 | 6,177 | |
Sex | |||
Male | 2,927 (47.4) | 2,921 (47.3) | |
Female | 3,241 (52.5) | 3,249 (52.6) | |
Not provided | 9 (0.1) | 7 (0.1) | .90 |
Age group, y | |||
<5 | 1,530 (24.8) | 1,487 (24.1) | |
5–17 | 403 (6.5) | 380 (6.1) | |
18–64 | 2,463 (39.9) | 2,478 (40.1) | |
≥65 | 1,781 (28.8) | 1,832 (29.7) | .20 |
Race | |||
Indigenous | 480 (7.8) | 517 (8.4) | |
Non-Indigenous | 2,979 (48.2) | 3,004 (48.6) | |
Not indicated in patient record | 2,718 (44.0) | 2,656 (43.0) | .34 |
Preexisting chronic medical conditions | |||
Diabetes | 874 (14.1) | 876 (14.2) | |
Chronic heart disease | 387 (6.2) | 421 (6.8) | |
Asthma | 1,935 (31.3) | 1,875 (30.3) | |
Chronic obstructive pulmonary disease | 179 (2.9) | 169 (2.7) | |
Impaired immunity | 148 (2.4) | 132 (2.1) | .58 |
Pregnanta | |||
Yes | 124 (14.9) | 115 (13.3) | |
No | 709 (85.1) | 747 (86.7) | .47 |
Record of influenza vaccine with practice | |||
Yes | 1,998 (32.3) | 2,011 (32.6) | |
No | 4,179 (67.7) | 4,166 (67.4) | .80 |
↵a Among reproductive women aged 19 to 44 years (n = 833 in intervention group; n = 862 in control group).